This scientific commentary refers to ‘MCAM brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4 T lymphocytes’ by Charabati . (https://doi.org/10.1093/brain/awac389).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115349 | PMC |
| http://dx.doi.org/10.1093/brain/awad079 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigation of Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer.
Biology (Basel)
December 2024
Department of Medical Biology, Faculty of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey.
HER2-positive breast cancer has an aggressive tumour progression among breast cancers characterized by the overexpression of HER2. Trastuzumab is an FDA-approved drug and has significantly improved outcomes for patients; however, drug resistance remains a major challenge. Tumour heterogeneity, describing genetic, epigenetic, and phenotypic differences within and between tumours, complicates tumour treatment and contributes to drug resistance.
View Article and Find Full Text PDFCombinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma.
Mol Ther Oncol
December 2024
Department of Pediatrics, New York Medical College, Valhalla, NY 10595, USA.
Pediatric patients with recurrent metastatic neuroblastoma (NB) have a dismal 5-year survival. Novel therapeutic approaches are urgently needed. The melanoma cell adhesion molecule (MCAM/CD146/MUC18) is expressed in a variety of pediatric solid tumors, including NB, and constitutes a novel target for immunotherapy.
View Article and Find Full Text PDFAntigen targeting and anti-tumor activity of a novel anti-CD146 Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma.
Sci Rep
October 2024
Oncoinvent ASA, 0484, Oslo, Norway.
Malignant mesothelioma, a highly aggressive cancer that primarily affects the serosal membranes, has limited therapeutic options, particularly for cavitary tumors, such as peritoneal and pleural malignant mesothelioma. Intracavitary administration of a radioimmunoconjugate to locally target mesothelioma cancer cells has been proposed as a treatment. CD146, upregulated in mesothelioma but not in healthy tissues, is a promising therapeutic target.
View Article and Find Full Text PDFThe vasculogenic mimicry, CD146 and CD105 microvessel density in the prognosis of endometrioid endometrial adenocarcinoma: a single-centre immunohistochemical study.
Biomarkers
November 2024
Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton, UK.
Article Synopsis
- The study focuses on the importance of the microvessel compartment in the tumor environment of endometrioid adenocarcinoma (EA) and explores the implications of vasculogenic mimicry (VM), CD146, and CD105 microvessel density on clinical prognosis.
- A total of 188 EA cases were examined using specific staining techniques, revealing that higher levels of VM channels and CD146/CD105 microvessels were linked to worse prognoses.
- The findings suggest that these factors could serve as independent indicators of prognosis and potential targets for antiangiogenic therapy, although further research is needed for confirmation.
Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation.
NPJ Breast Cancer
September 2024
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Cell state control is crucial for normal tissue development and cancer cell mimicry of stem/progenitor states, contributing to tumor heterogeneity, therapy resistance, and progression. Here, we demonstrate that the cell surface glycoprotein Mcam maintains the tumorigenic luminal progenitor (LP)-like epithelial cell state, leading to Basal-like mammary cancers. In the Py230 mouse mammary carcinoma model, Mcam knockdown (KD) destabilized the LP state by deregulating the Ck2/Stat3 axis, causing a switch to alveolar and basal states, loss of an estrogen-sensing subpopulation, and resistance to tamoxifen-an effect reversed by Ck2 and Stat3 inhibitors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!